Clinical Trials
14 trialsNCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
NCT03693807 2026-02-06
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03929666 2025-09-12
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals
Phase 2 Completed
NCT05733000 2023-03-10
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Northwestern University
Phase 2 Recruiting
NCT05725200 2023-02-21
EVIDENT
Oslo University Hospital
Phase 2 Recruiting
NCT00007943 2021-09-09
Gemcitabine in Treating Patients With Advanced Colorectal Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT04668976 2020-12-21
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Benaroya Research Institute
Phase 2 Unknown
NCT00276861 2017-02-08
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
University of Miami
Phase 2 Terminated
NCT01472770 2014-12-04
GemCaP
Vejle Hospital
Phase 2 Completed
NCT00159445 2014-05-22
Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer
University of Southern California
Phase 2 Completed
NCT01409005 2014-02-11
Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer
Seoul National University Bundang Hospital
Phase 2 Completed
NCT01109615 2012-04-19
PG
Vejle Hospital
Phase 2 Terminated
NCT00192075 2011-02-07
A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
Eli Lilly and Company
Phase 2 Completed
NCT00220155 2009-12-16
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
Royal Marsden NHS Foundation Trust
Phase 2 Completed